A scoping review of trials for cell-based therapies in human spinal cord injury (Q91583982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

review article

1 reference

title

A scoping review of trials for cell-based therapies in human spinal cord injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

Sam Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

Mark Kotter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

Susan C Barnett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

author name string

Benjamin M Davies

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

publication date

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

Traumatic spinal cord injury

23 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Are nestin-positive mesenchymal stromal cells a better source of cells for CNS repair?

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Human mesenchymal stem cells isolated from olfactory biopsies but not bone enhance CNS myelination in vitro.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

GDNF Schwann cells in hydrogel scaffolds promote regional axon regeneration, remyelination and functional improvement after spinal cord transection in rats

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Transplantation of olfactory mucosa following spinal cord injury promotes recovery in rats

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Stem cell based therapies for spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Recent therapeutic approaches for spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Delayed Results of Transplantation of Fetal Neurogenic Tissue in Patients with Consequences of Spinal Cord Trauma

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Autologous bone marrow cell transplantation in acute spinal cord injury--an Indian pilot study

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Long-term Results of Spinal Cord Injury Therapy Using Mesenchymal Stem Cells Derived From Bone Marrow in Humans

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Does timing of transplantation of neural stem cells following spinal cord injury affect outcomes in an animal model?

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Long-Term Outcome of Olfactory Ensheathing Cell Therapy for Patients with Complete Chronic Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Clinical Observation of Fetal Olfactory Ensheathing Glia Transplantation (OEGT) in Patients with Complete Chronic Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Intrathecal granulocyte colony-stimulating factor modulate glial cell line-derived neurotrophic factor and vascular endothelial growth factor A expression in glial cells after experimental spinal cord ischemia.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Transplantation of purified autologous leukapheresis-derived CD34 and CD133 stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report.

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Intramedullary cervical spinal mass after stem cell transplantation using an olfactory mucosal cell autograft

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

Choosing the right cell for spinal cord repair

1 reference

https://api.crossref.org/works/10.1038/S41393-020-0455-1

7 January 2021

10.1038/S41393-020-0455-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32249830 AND SRC:MED&resulttype=core&format=json

23 April 2020

1 reference